Corporate Glenmark Pharmaceuticals Limited April 9, 2026 Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated April 09, 2026, titled “Glenmark Pharmaceuticals Receives U.S. FDA Approval for Progesterone Vaginal Inserts, 100 mg”. |SUBJECT: Press Release Post navigation HBL Engineering Limited HBL Engineering Limited Related Posts PNGS Reva Diamond Jewellery Limited PNGS Reva Diamond Jewellery Limited has informed the Exchange about Schedule of meet |SUBJECT: Analysts/Institutional… March 10, 2026 Welspun Enterprises Limited WELSPUN ENTERPRISES LIMITED has informed the Exchange about the event related to Bagging/Receiving of orders/contracts… May 3, 2026 Wipro Limited Wipro Limited has informed the Exchange that pursuant to Regulation 30 of the SEBI (Listing… April 6, 2026 Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment.
PNGS Reva Diamond Jewellery Limited PNGS Reva Diamond Jewellery Limited has informed the Exchange about Schedule of meet |SUBJECT: Analysts/Institutional… March 10, 2026
Welspun Enterprises Limited WELSPUN ENTERPRISES LIMITED has informed the Exchange about the event related to Bagging/Receiving of orders/contracts… May 3, 2026
Wipro Limited Wipro Limited has informed the Exchange that pursuant to Regulation 30 of the SEBI (Listing… April 6, 2026